|
2010
|
Invention
|
Bicyclic amide derivatives for the treatment of respiratory depression. This invention relates to... |
|
|
Invention
|
Bicyclic amide derivatives for enhancing glutamatergic synaptic responses. This invention relates... |
|
2008
|
Invention
|
3-substituted-1,2,3-triazin-4-one's and 3 substituted 1,3-pyrimidinone's for enhancing glutamater... |
|
|
Invention
|
3-substituted 1,2,3-triazin-4-one's and 3-substituted 1,3-pyrimidinone's for enhancing glutamater... |
|
|
Invention
|
Bicyclic amides for enhancing glutamatergic synaptic responses.
This invention relates... |
|
|
Invention
|
Bicyclic amides for ehancing glutamatergic synaptic responses.
This invention relates ... |
|
|
Invention
|
Bicyclic amides for enhancing glutamatergic synaptic responses. This invention relates to compoun... |
|
|
Invention
|
Di-substituted amides for enhancing glutamatergic synaptic responses. This invention relates to c... |
|
2007
|
Invention
|
3-substituted-[1,2,3]-benzotriazinone compounds for enhancing glutamatergic synaptic responses.
... |
|
|
Invention
|
3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses. Th... |
|
|
Invention
|
3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses. Th... |
|
2005
|
Invention
|
Enhancement of ampakine-induced facilitation of synaptic responses by cholinesterase inhibitors. ... |
|
2004
|
Invention
|
Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses. This invention rela... |
|
|
Invention
|
Method of treating cognitive decline due to sleep deprivation and stress.
This inventi... |
|
|
Invention
|
Method of treating cognitive decline due to sleep deprivation and stress. This invention relates ... |
|
2002
|
Invention
|
Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses.
This inv... |
|
1998
|
Invention
|
Benzoxazine compounds for enhancing synaptic response. Compounds having a certain benzoxazine rin... |
|
|
Invention
|
Treatment of schizophrenia with ampakines and neuroleptics. This invention relates to treatment o... |
|
|
Invention
|
Treatment of schizophrenia with ampakines and neuroleptics.
This invention relates to ... |
|
|
Invention
|
Benzofurazan compounds which enhance ampa receptor activity. Compounds of general structural form... |
|
1997
|
Invention
|
Benzoxazines for enhancing synaptic response. Compounds of formula (I) in which R?1 and R2¿ are i... |
|
1996
|
Invention
|
Benzoyl piperidines/pyrrolidines for enhancing synaptic response. Benzoyl piperidines and pyrroli... |
|
|
Invention
|
Benzoxazines for enhancing synaptic response. Compounds based on the benzoxazine ring system ##ST... |
|
1995
|
Invention
|
Use of metabotropic receptor agonists in progressive neurodegenerative diseases. A method of trea... |
|
1994
|
Invention
|
Alkaline and acid phosphatase inhibitors in treatment of neurological disorders. The present inve... |
|
|
Invention
|
Alkaline and acid phosphatase inhibitors in treatment of neurological disorders.
The p... |
|
|
Invention
|
Use of metabotropic receptor agonists in progressive neurodegenerative deseases. A pharmaceutical... |
|
1993
|
Invention
|
Optically pure calpain inhibitor compounds. Optically pure .alpha.-ketoamide compounds, and use t... |
|
|
Invention
|
Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with i... |
|
1991
|
Invention
|
Use of calpain inhibitors in the inhibition and treatment of neurodegeneration. The present inven... |
|
|
Invention
|
Use of calpain inhibitors in the inhibition and treatment of neurodegeneration. 2098609 9211850 P... |
